This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Ucbbiopharma Srl. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: John Paul Silva: Innovator in Antibody Research
Introduction
John Paul Silva is a notable inventor based in Slough, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work has the potential to impact various therapeutic areas, showcasing his dedication to advancing medical science.
Latest Patents
John Paul Silva holds a patent for "Antibodies Against Interleukin-22." This innovation represents a crucial step in understanding and potentially treating conditions related to interleukin-22, a cytokine involved in immune responses.
Career Highlights
Silva is currently employed at UCB Biopharma Srl, where he continues to push the boundaries of research and development in biopharmaceuticals. His expertise in antibody technology has positioned him as a valuable asset in his field.
Collaborations
Throughout his career, Silva has collaborated with talented individuals such as Joseph Michael David Rastrick and Zainab Ahdash. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
John Paul Silva's contributions to antibody research exemplify the spirit of innovation in biotechnology. His work not only advances scientific knowledge but also holds promise for future therapeutic applications.